Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Medication Adjustment for Alzheimer's Patients

Rationale for Adding Memantine

  • The American Academy of Neurology suggests that memantine works through a different mechanism than cholinesterase inhibitors, acting as an NMDA receptor antagonist, providing complementary therapeutic effects 1

Implementation Strategy

  • The American College of Physicians recommends initiating memantine while continuing donepezil at the current dose, with a target dose of 20 mg/day, and continuing donepezil at the established therapeutic dose, typically 10 mg/day 4, 1

Critical Considerations Before Adding Memantine

  • The Alzheimer's Association advises assessing for delirium due to infections or toxic-metabolic causes, reviewing all medications for anticholinergic adverse effects, ensuring comorbid conditions are optimally treated, and verifying medication adherence with the current donepezil regimen 2, 1, 5
  • The American Geriatrics Society suggests ensuring comorbid conditions such as stroke or depression are optimally treated before adding memantine 2

Expected Outcomes and Monitoring

  • The American Academy of Neurology indicates that combination therapy provides modest but clinically meaningful benefits, and patients are more likely to show smaller decline or improvement in both cognitive and functional measures, with benefits maintained throughout the study period 1

Common Pitfalls to Avoid

  • The American College of Physicians recommends not discontinuing donepezil when adding memantine, as the evidence specifically supports combination therapy, not substitution, and discontinuing donepezil leads to significant worsening of both cognition and function 1
  • The Alzheimer's Association advises recognizing that rapid cognitive decline may indicate more aggressive disease, and patients with MMSE <20 at treatment onset, vascular risk factors, or rapid decline require more frequent monitoring 2